2.5.11.1. The purpose of this section is to highlight known technological challenges which may impact the ability to reach the level of performance identified in the performance attributes (KPPs, KSAs, or APAs), or represent risk to delivering capabilities on schedule and within budget. This information from the Technology Readiness Assessment (TRA) may be used to inform lifecycle cost, performance, schedule, and quantity tradeoff discussions during review and validation of the CDD.

2.5.11.1.1. For the CDD generated prior to the Milestone B acquisition decision, this section identifies technological risk areas that require attention during the EMD phase of acquisition.

2.5.11.1.2. In cases where the CDD describes multiple increments of a capability solution, this section must describe the critical technologies to be matured for each increment. This may also be addressed in the incremental annex as they are developed for a capability solution.